Phase II Study of the Histone-deacetylase Inhibitor GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Patients With JAK2V617F Positive Polycythemia Vera Non-responder to Hydroxyurea Monotherapy.
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2012
At a glance
- Drugs Givinostat; Hydroxycarbamide
- Indications Polycythaemia vera
- Focus Therapeutic Use
- 16 Dec 2011 New trial record
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.